Schedule of Warrant Outstanding Issued Exercised and Expired (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Number of warrants outstaning, Balance | 351,528 |
| Weighted average exercise price, Balance | 4.75 |
| Expiration date | 2029 |
| Number of warrants, Issued | 475,968 |
| Weighted average exercise price, issued | 11.24 |
| Expiration Date, Issued | 2031 |
| Number of warrants, Exercised | |
| Number of warrants, Expired | |
| Number of warrants outstaning, Balance | 827,496 |
| Weighted average exercise price, Balance | 8.48 |
| Minimum [Member] | |
| Expiration date | 2029 |
| Maximum [Member] | |
| Expiration date | 2031 |
| X | ||||||||||
- Definition Issued warrants expiration term. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price per share issued. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Warrants expiration term. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|